Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Spicer

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2011
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brainMariam Jamal-Hanjani, James Spicer
Frontiers in Immunology|April 19, 2021
Why Haven't We Found an Effective Treatment for COVID-19?Alexander James Spicer, Sirpa Jalkanen
Nature Reviews. Clinical Oncology|April 17, 2020
Provision of cancer care during the COVID-19 pandemicJames Spicer, Charlotte Chamberlain, Sophie Papa
Cancer Letters|October 13, 2006
Targeting novel and established therapies for non-small cell lung cancerJames Spicer, Simon Chowdhury, Peter Harper
Targeted Oncology|September 22, 2009
Molecular imaging in clinical trialsDebra Josephs, James Spicer, Michael O'Doherty
Lancet (London, England)|August 23, 2005
Adjuvant trastuzumab for HER2-positive breast cancerJames Spicer, Mark Harries, Paul Ellis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2013
Reply to A. Surbone et alJames Spicer, Henrik Moller, Sophie Papa
Oncotarget|October 20, 2018
Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agentsEmma J Jordan, James Spicer, Debashis Sarker
Future Oncology (London, England)|June 4, 2015
Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lungPeter E Hall, James Spicer, Sanjay Popat
Expert Opinion on Pharmacotherapy|August 10, 2005
Combination therapy versus single agent chemotherapy in non-small cell lung cancerKerry Cheong, James Spicer, Simon Chowdhury, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2011
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brainMariam Jamal-Hanjani, James Spicer
Frontiers in Immunology|April 19, 2021
Why Haven't We Found an Effective Treatment for COVID-19?Alexander James Spicer, Sirpa Jalkanen
Nature Reviews. Clinical Oncology|April 17, 2020
Provision of cancer care during the COVID-19 pandemicJames Spicer, Charlotte Chamberlain, Sophie Papa
Cancer Letters|October 13, 2006
Targeting novel and established therapies for non-small cell lung cancerJames Spicer, Simon Chowdhury, Peter Harper
Targeted Oncology|September 22, 2009
Molecular imaging in clinical trialsDebra Josephs, James Spicer, Michael O'Doherty
Lancet (London, England)|August 23, 2005
Adjuvant trastuzumab for HER2-positive breast cancerJames Spicer, Mark Harries, Paul Ellis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2013
Reply to A. Surbone et alJames Spicer, Henrik Moller, Sophie Papa
Oncotarget|October 20, 2018
Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agentsEmma J Jordan, James Spicer, Debashis Sarker
Future Oncology (London, England)|June 4, 2015
Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lungPeter E Hall, James Spicer, Sanjay Popat
Expert Opinion on Pharmacotherapy|August 10, 2005
Combination therapy versus single agent chemotherapy in non-small cell lung cancerKerry Cheong, James Spicer, Simon Chowdhury, et al.
Pageof 14